Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation: The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) Study
Year: 2008
Type: article
Study design: Clinical Trial
Source: Hypertension
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: hydrochlorothiazide, candesartan, insulin resistance, visceral fat, hepatic lipid accumulation, thiazide diuretics, angiotensin receptor blockers, type 2 diabetes prevention, abdominal obesity, hepatic steatosis, subcutaneous adipose tissue, low-grade inflammation, C-reactive protein, insulin sensitivity, first-phase insulin secretion, intramyocellular lipid
Open Access status: closed
Funders: AstraZeneca, Vetenskapsrådet
OpenAlex ID: W2168493982
